The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting
{{output}}
Introduction: The Oncotype DX test is a genomic assay that generates a Recurrence Score (RS) predicting the 10-year risk of recurrence and response to adjuvant chemotherapy in ER+/HER2- breast cancer patients. The aims were to de... ...
